Continues to Diligently Defend Against the Dissenting Investor Group’s Multi-Jurisdictional Legal Tactics to Block the US$55.00 Per Common Share Cash Dividend BEIJING--(BUSINESS WIRE)--The Board of ...
Sinovac Biotech Ltd. (NASDAQ: SVA) (“ SINOVAC ” or the “ Company ”), a leading provider of biopharmaceutical products in China, today announced that it has extended the deadline for shareholders and ...
Add Yahoo as a preferred source to see more of our stories on Google. People who were originally fully vaccinated with the Chinese-made Sinovac COVID-19 vaccine were shown to develop a high degree of ...
BEIJING--(BUSINESS WIRE)--The Board of Directors of SINOVAC Biotech Ltd. (NASDAQ: SVA) (“SINOVAC” or the “Company”), a leading biopharmaceutical company in China, categorically rejects the recent ...
Add Yahoo as a preferred source to see more of our stories on Google. FILE PHOTO: A medical worker holds a dose of the Sinovac vaccine at a district health facility as Indonesia begins mass ...
View Sinovac Biotech Ltd. SVA stock quote prices, financial information, real-time forecasts, and company news from CNN.
The Company posted $21.7 million of net loss attributable to common shareholders, or a loss of $0.30 per basic and diluted share, in the six months ended June 30, 2025, compared to net income ...
BEIJING, Sept 6 (Reuters) - (This September 6 story corrected spelling of Fudan University from Furan in paragraph 5) A booster dose of Sinovac Biotech's (SVA.O), opens new tab COVID-19 vaccine ...
BEIJING (Reuters) - Sinovac Biotech's COVID-19 vaccine appears to be safe and able to trigger immune responses among children and adolescents, according to preliminary results from early and mid-stage ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results